Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_assertion type Assertion NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_head.
- NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_assertion description "[Interestingly, drugs used for other diseases, such as statins, Rho-kinase inhibitors, imatinib mesylate, may control the pathological vascular remodeling of PAH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_provenance.
- NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_assertion evidence source_evidence_literature NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_provenance.
- NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_assertion SIO_000772 17346158 NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_provenance.
- NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_assertion wasDerivedFrom befree-20150227 NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_provenance.
- NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_assertion wasGeneratedBy ECO_0000203 NP674057.RAbO09KtcRPP_Axg2MDnyIdh0vK1EQ0VPIr21opdJA6-Y130_provenance.